Special 510(k) proposal's requirement for design control activities summary too burdensome -- J&J.
This article was originally published in The Gray Sheet
Executive Summary
SPECIAL 510(k) POLICY's SUMMARY OF DESIGN CONTROL ACTIVITIES requires an "unprecedented" level of "detailed GMP information," Johnson & Johnson asserts in Nov. 18 comments to FDA. The content requirements for the design control summary stipulated by the agency move the 510(k) review process "in the wrong direction," J&J says.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.